tiprankstipranks
Trending News
More News >
Immunic, Inc. (IMUX)
:IMUX
Advertisement

Immunic (IMUX) Stock Statistics & Valuation Metrics

Compare
1,707 Followers

Total Valuation

Immunic has a market cap or net worth of $90.03M. The enterprise value is $37.86M.
Market Cap$90.03M
Enterprise Value$37.86M

Share Statistics

Immunic has 98,650,590 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding98,650,590
Owned by Insiders1.28%
Owned by Institutions28.83%

Financial Efficiency

Immunic’s return on equity (ROE) is -5.45 and return on invested capital (ROIC) is -504.56%.
Return on Equity (ROE)-5.45
Return on Assets (ROA)-2.46
Return on Invested Capital (ROIC)-504.56%
Return on Capital Employed (ROCE)-5.25
Revenue Per Employee0.00
Profits Per Employee-1.10M
Employee Count91
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Immunic is ―. Immunic’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value5.44
Price to FCF
Price to Operating Cash Flow-1.32
PEG Ratio

Income Statement

In the last 12 months, Immunic had revenue of 0.00 and earned -100.51M in profits. Earnings per share was -1.00.
Revenue0.00
Gross Profit-134.00K
Operating Income-98.05M
Pretax Income-100.51M
Net Income-100.51M
EBITDA-100.37M
Earnings Per Share (EPS)-1.00

Cash Flow

In the last 12 months, operating cash flow was -90.15M and capital expenditures -136.00K, giving a free cash flow of -90.29M billion.
Operating Cash Flow-90.15M
Free Cash Flow-90.29M
Free Cash Flow per Share-0.92

Dividends & Yields

Immunic pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.33
52-Week Price Change-35.62%
50-Day Moving Average0.86
200-Day Moving Average1.01
Relative Strength Index (RSI)52.91
Average Volume (3m)1.11M

Important Dates

Immunic upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date

Financial Position

Immunic as a current ratio of 1.77, with Debt / Equity ratio of 2.89%
Current Ratio1.77
Quick Ratio1.77
Debt to Market Cap0.00
Net Debt to EBITDA0.35
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Immunic has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Immunic EV to EBITDA ratio is -0.65, with an EV/FCF ratio of -0.77.
EV to Sales0.00
EV to EBITDA-0.65
EV to Free Cash Flow-0.77
EV to Operating Cash Flow-0.77

Balance Sheet

Immunic has $55.31M in cash and marketable securities with $979.00K in debt, giving a net cash position of -$54.33M billion.
Cash & Marketable Securities$55.31M
Total Debt$979.00K
Net Cash-$54.33M
Net Cash Per Share-$0.55
Tangible Book Value Per Share$0.18

Margins

Gross margin is -62.28%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-62.28%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Immunic is $6.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.33
Price Target Upside595.60% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast
EPS Growth Forecast35.46%

Scores

Smart Score6
AI Score36.75
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis